Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Software Link with Picis

25 Apr 2006 07:00

For immediate release 25 April 2006 LiDCO Group plc Software Link with Picis LiDCO Group plc (AIM: LID), the cardiovascular monitoring company, is pleasedto announce that Picis, the leading provider of high-acuity care automationsoftware for hospitals, is to create a custom device link between LiDCO'sproprietary, stand-alone monitoring system and the Picis CareSuite¢â€ž¢ hospitalinformation management system (HIS) or any other HIS that Picis communicatesto. Once completed, the communications link will allow Picis customers accessto LiDCO's proprietary, minimally-invasive hemodynamic monitoring data. Theintegration of critical care parameters and data derived from the LiDCOplusmonitor will allow a full picture of the patient's condition and history to bedisplayed and accessed throughout the hospital.LiDCO's CEO, Dr. Terry O'Brien, commented: "The communications link willfurther enhance the utility of the LiDCOplus system for both our existing andfuture Picis customers. LiDCO will continue to explore additional non-exclusivecollaborations with the major corporations providing monitoring products to theacute care hospital market. Our ambition is to make LiDCO's technology thestandard of care throughout the hospital for minimally-invasive hemodynamicmonitoring."For further information please contact:LiDCO Group Plc Tel: +44 (0)20 7749 1500 Terry O'Brien - Chief Executive Hugh McGarel-Groves - Finance Director Buchanan Communications Tim Anderson, James Strong Tel: +44 (0)20 7466 5000 Panmure Gordon Grant Harrison, Aubrey Powell, Katherine Roe Tel: +44 (0)20 7459 3600 Notes to EditorsAbout LiDCO PlcLiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier ofminimally invasive, computer-based hemodynamic monitoring equipment anddisposables used primarily for the management of critical care andcardiovascular risk hospital patients. Use of LiDCO's technology has been shownto significantly reduce the complications (particularly infections) and costsassociated with major surgery. The technology was invented in the Department ofApplied Physiology based at St Thomas' Hospital, London where the Companymaintains a research base.The Company's manufacturing facility is in Hoxton, London and its currentproducts are: * LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume; * LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner. Distribution Network:The Company has now achieved registration of its products in 16 markets inEurope, the USA, Brazil and Japan. It sells direct to the NHS in the UK, andthrough a worldwide network of specialty critical care distributors.About PicisPicis is the leading, worldwide provider of information systems that deliverproven best-in-cluster patient care transformation for the highest-acuity careareas of the hospital - the emergency department, the operating room and theintensive care unit. Headquartered in Wakefield, Massachusetts, Picis hasinstalled systems in more than 900 medical centers and hospital networksworldwide including over 700 in North America, automating more surgicalprocedures, emergency visits and intensive care stays than any other company inthe world. Picis has received numerous awards, including those from Microsoft,Ernst & Young, HCIT Research, Healthcare Informatics and Frost and Sullivan.Picis was recently named to both the Deloitte & Touche Fast 500 and the Inc.Magazine 500 lists (105th overall) of the fastest growing private companies inthe U.S. More information is available at www.picis.com.ENDLIDCO GROUP PLC
Date   Source Headline
26th Jan 20064:38 pmPRNConvertible loan update
19th Jan 20067:00 amRNSProduct Development
19th Dec 20051:15 pmPRNResignation of a Director
8th Dec 20059:02 amPRNDirector Shareholding
18th Nov 20057:00 amRNSConversion of Loan
8th Nov 20057:01 amRNSPositive Study Data
3rd Nov 20057:00 amRNSUS Army Order
25th Oct 20057:01 amRNSClinical Advisory Board
18th Oct 20057:01 amRNSInterim Results
14th Oct 20051:39 pmPRNDirectorate Change
26th Sep 20059:11 amRNSNotice of Results
11th Aug 20057:02 amRNSUSD 2 Million Financing
14th Jul 20057:00 amRNSAdditional Listing
7th Jul 20057:01 amRNSNew Veterinary Application
23rd Jun 20054:00 pmRNSImpact of Review Paper
17th Jun 20057:00 amRNSBoard Appointment
16th Jun 20052:57 pmRNSAGM Statement
6th Jun 20052:38 pmPRNDirector Shareholding
1st Jun 20057:00 amRNSPositive Data
10th May 20052:20 pmPRNDirector Shareholding
9th May 20057:00 amRNSRegistration in Brazil
25th Apr 20057:00 amRNSAppointment of New Director
15th Apr 200511:46 amRNSDirector Shareholding
13th Apr 20057:00 amRNSDirector Share Options Award
7th Apr 20057:00 amRNSDirector Shareholding
30th Mar 20057:01 amRNSPreliminary Results
30th Mar 20057:01 amRNSProduct Approval in Denmark
24th Mar 20057:02 amRNSLaunch Of Software Upgrade
23rd Mar 200510:50 amPRNAdditional Listing
21st Mar 20057:02 amRNSSignificant Trial Results
15th Mar 20057:02 amRNSEuropean Approval
2nd Mar 20058:19 amRNSChange of Financial PR Agency
14th Feb 20057:00 amPRNMajor Clinical Trial
24th Jan 20053:25 pmPRNAdditional Listing
19th Jan 20054:16 pmPRNDirectorate Change
13th Jan 200511:28 amPRNAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.